PortfoliosLab logoPortfoliosLab logo
ISIN
US63633D1046
CUSIP
63633D104
IPO Date
Oct 9, 1991

Highlights

Market Cap
$3.44B
Enterprise Value
$3.42B
EPS (TTM)
$3.12
PE Ratio
22.77
PEG Ratio
0.21
Total Revenue (TTM)
$402.19M
Gross Profit (TTM)
$210.78M
EBITDA (TTM)
$233.74M
Year Range
$67.94 - $91.38
Target Price
$85.40
ROA (TTM)
5.12%
ROE (TTM)
9.77%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

NHI Performance Chart

National Health Investors, Inc. (NHI) is down 6.0% since the beginning of the year. At $71 per share, NHI is trading 22.3% below its 52-week high of $91. Investors who bought $1,000 worth of NHI shares 5 years ago would now be looking at an investment worth $1,396.


Loading charts...

S&P 500 Index

Returns By Period

National Health Investors, Inc. (NHI) has returned -6.03% so far this year and 5.17% over the past 12 months. Over the last ten years, NHI has returned 5.61% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


National Health Investors, Inc.

1D
0.20%
1M
-7.14%
YTD
-6.03%
6M
-4.98%
1Y
5.17%
3Y*
17.60%
5Y*
6.90%
10Y*
5.61%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NHI Monthly Returns History

Based on dividend-adjusted daily data since Oct 9, 1991, NHI's average daily return is +0.06%, while the average monthly return is +1.22%. At this rate, an investment would double in approximately 4.8 years.

Historically, 59% of months were positive and 41% were negative. The best month was Jan 2001 with a return of +32.3%, while the worst month was Mar 2020 at -38.2%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 5 months.

On a daily basis, NHI closed higher 50% of trading days. The best single day was Aug 18, 2000 with a return of +20.7%, while the worst single day was Mar 16, 2020 at -33.1%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20267.53%2.37%-2.73%-4.88%-4.71%-3.18%-6.03%
2025-1.72%5.23%4.31%2.45%-4.18%-2.05%-0.37%12.07%2.75%-6.28%6.67%-2.76%15.69%
2024-4.78%8.07%10.95%0.37%4.79%3.88%10.53%8.78%4.35%-8.82%0.00%-8.39%30.71%
202312.66%-6.51%-4.52%-3.51%4.70%2.35%4.75%-6.88%2.26%-2.57%8.43%4.57%14.57%
20220.63%-7.82%12.36%-12.68%14.79%3.99%6.98%1.03%-12.33%0.30%-0.78%-5.57%-3.26%
2021-6.26%5.29%7.46%1.56%-10.22%3.09%1.76%-12.33%-9.08%0.52%-2.86%11.75%-11.74%

Benchmark Metrics

National Health Investors, Inc. has an annualized alpha of 8.73%, beta of 0.73, and R2 of 0.19 versus S&P 500 Index. Calculated based on daily prices since October 09, 1991.

  • This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (80.64%) than losses (63.24%) - typical of diversified or defensive assets.
  • R2 of 0.19 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
8.73%
Beta
0.73
0.19
Upside Capture
80.64%
Downside Capture
63.24%

Return for Risk

Risk / Return Rank

NHI ranks 46 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


NHI Risk / Return Rank: 4646
Overall Rank
NHI Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
NHI Sortino Ratio Rank: 4242
Sortino Ratio Rank
NHI Omega Ratio Rank: 4242
Omega Ratio Rank
NHI Calmar Ratio Rank: 4747
Calmar Ratio Rank
NHI Martin Ratio Rank: 4949
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for National Health Investors, Inc. (NHI) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NHIBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-1.79

Sortino ratioReturn per unit of downside risk

-2.29

Omega ratioGain probability vs. loss probability

1.06

1.37

-0.31

Calmar ratioReturn relative to maximum drawdown

0.22

2.78

-2.57

Martin ratioReturn relative to average drawdown

0.63

12.44

-11.81

Dividends

Dividend History

National Health Investors, Inc. provided a 5.16% dividend yield over the last twelve months, with an annual payout of $3.66 per share. The company has been increasing its dividends for 3 consecutive years.


5.00%5.50%6.00%6.50%7.00%$0.00$1.00$2.00$3.00$4.0020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$3.66$3.64$3.60$3.60$3.60$3.80$4.41$4.20$4.00$3.80$3.60$3.40

Dividend yield

5.16%4.77%5.19%6.45%6.89%6.62%6.38%5.15%5.30%5.04%4.85%5.59%

Monthly Dividends

The table displays the monthly dividend distributions for National Health Investors, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.92$0.00$0.00$0.00$0.92
2025$0.00$0.00$0.90$0.00$0.00$0.90$0.00$0.00$0.92$0.00$0.00$0.92$3.64
2024$0.00$0.00$0.90$0.00$0.00$0.90$0.00$0.00$0.90$0.00$0.00$0.90$3.60
2023$0.00$0.00$0.90$0.00$0.00$0.90$0.00$0.00$0.90$0.00$0.00$0.90$3.60
2022$0.00$0.00$0.90$0.00$0.00$0.90$0.00$0.00$0.90$0.00$0.00$0.90$3.60
2021$0.00$0.00$1.10$0.00$0.00$0.90$0.00$0.00$0.90$0.00$0.00$0.90$3.80

Dividend Yield & Payout


Dividend Yield

National Health Investors, Inc. has a dividend yield of 5.16%, which is quite average when compared to the overall market.

Payout Ratio

National Health Investors, Inc. has a payout ratio of 116.87%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the National Health Investors, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the National Health Investors, Inc. was 82.88%, occurring on Aug 17, 2000. Recovery took 761 trading sessions.

The current National Health Investors, Inc. drawdown is 21.16%.


Related event

Drawdown

Fall

Recovery

Underwater

Dot-com crash2000–2002
-82.88%Aug 2000
2y 8mo3y 16d
5y 8moDec 1997 - Sep 2003
COVID crash2020
-63.04%Mar 2020
23d4y 3mo
4y 4moFeb 2020 - Jun 2024
Financial crisis2007–2009
-45.52%Nov 2008
1mo 21d8mo 16d
10mo 7dOct 2008 - Aug 2009
2015 bear market2015
-27.41%Sep 2015
7mo 7d9mo 10d
1y 4moJan 2015 - Jun 2016
2004 bear market2004
-27.34%May 2004
1mo 9d6mo 25d
8mo 4dApr 2004 - Dec 2004

Drawdown Indicators


NHIBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-82.88%

-56.78%

-26.10%

Max Drawdown (1Y)

Largest decline over 1 year

-24.09%

-9.10%

-14.99%

Max Drawdown (3Y)

Largest decline over 3 years

-24.09%

-18.90%

-5.19%

Max Drawdown (5Y)

Largest decline over 5 years

-25.68%

-25.43%

-0.25%

Max Drawdown (10Y)

Largest decline over 10 years

-63.04%

-33.92%

-29.12%

Current Drawdown

Current decline from peak

-21.16%

-1.80%

-19.36%

Average Drawdown

Average peak-to-trough decline

-15.01%

-10.71%

-4.30%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.23%

2.03%

+6.20%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of National Health Investors, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how National Health Investors, Inc. is priced in the market compared to other companies in the REIT - Healthcare Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for NHI, comparing it with other companies in the REIT - Healthcare Facilities industry. Currently, NHI has a P/E ratio of 22.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for NHI compared to other companies in the REIT - Healthcare Facilities industry. NHI currently has a PEG ratio of 0.2. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for NHI relative to other companies in the REIT - Healthcare Facilities industry. Currently, NHI has a P/S ratio of 8.4. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for NHI in comparison with other companies in the REIT - Healthcare Facilities industry. Currently, NHI has a P/B value of 2.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with NHI

Add National Health Investors, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with NHI